Unknown PHASE4 INTERVENTIONAL 2-arm NCT01238705

Combined Antihypertensive Therapy and Sexual Dysfunction

Effect of Combined Antihypertensive Therapy on Blood Pressure and Sexual Function in Patients With Essential Hypertension

Sponsor: LanZhou University

Conditions Hypertension Sexual Dysfunction

Interventions Felodipine add Irbesartan Felodipine add Metoprolol

Updated 5 times since 2017 Last updated: Nov 10, 2010 Started: Apr 30, 2008 Primary completion: Oct 31, 2010 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01238705, this PHASE4 trial focuses on Hypertension and Sexual Dysfunction and remains ongoing. Sponsored by LanZhou University, it has been updated 5 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

LanZhou University

Data source: LanZhou University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lanzhou, China